Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012652

CHIEF FINANCIAL OFFICER bought 30,000 shares at $1.10 ($33,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
VAN VOORHEES SETH CHIEF FINANCIAL OFFICER 2022-12-16 Purchase +30,000 $1.10 $33,000 46,337 D
Open-market purchases · 30,000 sh · avg $1.10 · $33,000
Loading xslF345X03/form4-12192022_121236.xml…